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Abstract The concentrations of 12 pharmaceutical com-
pounds (atenolol, erythromycin, cyclophosphamide, paracet-
amol, bezafibrate, carbamazepine, ciprofloxacin, caffeine,
clarithromycin, lidocaine, sulfamethoxazole and N-
acetylsulfamethoxazol (NACS)) were investigated in the in-
fluents and effluents of two hospital wastewater treatment
plants (HWWTPs) in Saudi Arabia. The majority of the target
analytes were detected in the influent samples apart from
bezafibrate, cyclophosphamide, and erythromycin. Caffeine
and paracetamol were detected in the influent at particularly
high concentrations up to 75 and 12 ug/L, respectively. High
removal efficiencies of the pharmaceutical compounds were
observed in both HWWTPs, with greater than 90 % removal
on average. Paracetamol, sulfamethoxazole, NACS, cipro-
floxacin, and caffeine were eliminated by between >95 and
>99 % on average. Atenolol, carbamazepine, and
clarithromycin were eliminated by >86 % on average. Of par-
ticular interest were the high removal efficiencies of carba-
mazepine and antibiotics that were achieved by the
HWWTPs; these compounds have been reported to be rela-
tively recalcitrant to biological treatment and are generally
only partially removed. Elevated temperatures and high levels
of sunlight were considered to be the main factors that en-
hanced the removal of these compounds.
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Introduction
Pharmaceutical compounds include a wide range of chemicals
with different structures, functions, behaviors, and activities
and are used to enhance human health in the medical field.
After their excretion by patients, these compounds and their
metabolites can contaminate surface water, ground water, and
drinking water (Kolpin et al. 2002;Monteiro and Boxall 2010;
Li et al. 2013; Schaider et al. 2014). The main sources of these
compounds and their metabolites in aquatic environments are
wastewater treatment plants (but can also include sources such
as manufacturing wastes and veterinary sources) (Vieno et al.
2007; Phillips et al. 2010; Vulliet et al. 2011; Tewari et al.
2013). Previous studies have detected high concentrations of
some pharmaceuticals in hospital wastewaters (Ohlsen et al.
2003; Kosma et al. 2010; Kovalova et al. 2012). Hospital
wastewater is, in most cases, connected directly to urban sew-
er systems without pretreatment, somunicipal wastewaters are
usually cotreated with hospital wastewater in municipal
wastewater treatment plants (MWWTPs) (Alder et al. 2006);
however, municipal systems are not usually designed to re-
move medical or pharmaceutical wastes.
Various methods for the removal of pharmaceuticals from
wastewater have been studied such as conventional activated
sludge (AS) (Oppenheimer et al. 2007; Nielsen et al. 2013)
membrane bioreactors (MBRs) (Clara et al. 2005; Radjenović
et al. 2009; Kim et al. 2014; Verlicchi et al. 2010; Kovalova
et al. 2012), and moving bed biofilm reactors (MBBRs)
(Escola Casas et al. 2015) as shown in Table 1 with regard
to compounds analyzed in this study. Currently, the AS
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Table 1 Comparison of removal efficiencies of pharmaceutical compounds in various wastewater treatment processes for hospital wastewater
(HWWTP) and municipal wastewater (MWWTP)
Compound Treatment plant type Removal (%) Reference
Paracetamol HWWTPAS + disinfection (GR) 75 Kosma et al. (2010)
MWWTPAS + sand filter (GR) 95.6 Kosma et al. (2010)
MWWTPAS + trickling filter (UK) 94 Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UK) >99 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CH) >99 Kovalova et al. (2012)
HWWTP MBR (pilot scale) (ceramic UF) (DK) >99 Nielsen et al. (2013)
Carbamazepine HWWTPAS + disinfection (GR) 30 Kosma et al. (2010)
MWWTPAS + sand filter (GR) NR Kosma et al. (2010)
MWWTP (+ industrial) AS (ES) NR Radjenović et al. (2009)
MWWTP (+ industrial) MBRc (pilot scale) (ES) NR Radjenović et al. (2009)
MWWTP (+ industrial) MBRd (pilot scale) (ES) NR Radjenović et al. (2009)
HWWTP MBBR (pilot scale) (DK) 10 Escola Casas et al. (2015)
MWWTPAS + trickling filter (UK) NR Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UK) 13 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CH) −6 ± 12 Kovalova et al. (2012)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 1 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) 28 Kim et al. (2014)
Atenolol MWWTP (+ industrial) AS (ES) 61.2 ± 18.6 Radjenović et al. (2009)
MWWTP (+ industrial) MBRc (pilot scale) (ES) 76.7 ± 12.6 Radjenović et al. (2009)
MWWTP (+ industrial) MBRd (pilot scale) (ES) 69.5 ± 12.5 Radjenović et al. (2009)
HWWTP MBBR (pilot scale) (DK) 40 Escola Casas et al. (2015)
MWWTPAS+ trickling filter (UK) 78 Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UK) 85 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CH) 99 ± 1 Kovalova et al. (2012)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 70 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) (CAN) 77 Kim et al. (2014)
Bezafibrate MWWTP (+ industrial) AS (ES) 80.8 ± 20.9 Radjenović et al. (2009)
MWWTP (+ industrial) MBRc (pilot scale) (ES) 90.3 ± 10.1 Radjenović et al. (2009)
MWWTP (+ industrial) MBRd (pilot scale) (ES) 88.2 ± 15.3 Radjenović et al. (2009)
MWWTPAS + trickling filter (UK) 45 Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UK) 71 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CH) >91 Kovalova et al. (2012)
Lidocaine HWWTP MBR (pilot scale) (CH) 56 ± 13 Kovalova et al. (2012)
Ciprofloxacin HWWTP MBR (pilot scale) (CH) 51 ± 13 Kovalova et al. (2012)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 36 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) (CAN) 89 Kim et al. (2014)
Clarithromycin HWWTP MBR (pilot scale) (CH) 50 ± 12 Kovalova et al. (2012)
MWWTPAS + UV (TW) NR Lin et al. (2010)
MWWTPAS + chlorination (TW) NR Lin et al. (2010)
MWWTPAS + chlorination (TW) 10 Lin et al. (2010)
MWWTPAS + sand filer (TW) NR Lin et al. (2010)
MWWTP trickling filter + chlorination (TW) 99 Lin et al. (2010)
MWWTPAS + chlorination (TW) NR Lin et al. (2010)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 64 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) (CAN) NR Kim et al. (2014)
Sulfamethoxazole MWWTP (+ industrial) AS (ES) 73.8 ± 12.7 Radjenović et al. (2009)
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Table 1 (continued)
Compound Treatment plant type Removal (%) Reference
MWWTP (+ industrial) MBRc (pilot scale) (ES) 80.8 ± 12.2 Radjenović et al. (2009)
MWWTP (+ industrial) MBRd (pilot scale) (ES) 78.3 ± 13.9 Radjenović et al. (2009)
HWWTP MBBR (pilot scale) (DK) NR Escola Casas et al. (2015)
MWWTPAS+ trickling filter (UK) 66 Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UK) 83 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CH) 7 ± 57 Kovalova et al. (2012)
MWWTPAS + UV (TW) 42 Lin et al. (2010)
MWWTPAS + chlorination (TW) 20 Lin et al. (2010)
MWWTPAS + chlorination (TW) 59 Lin et al. (2010)
MWWTPAS + sand filter (TW) 88 Lin et al. (2010)
MWWTP trickling filter + chlorination (TW) 45 Lin et al. (2010)
MWWTPAS + chlorination (TW) 26 Lin et al. (2010)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 97 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) (CAN) 66 Kim et al. (2014)
Erythromycin MWWTP (+ industrial) AS (ES) 35.4 ± 50.5 Radjenović et al. (2009)
MWWTP (+ industrial) MBRc (pilot scale) (ES) 43.0 ± 51.5 Radjenović et al. (2009)
MWWTP (+ industrial) MBRd (pilot scale) (ES) 25.2 ± 108.9 Radjenović et al. (2009)
HWWTP MBBR (pilot scale) (DK) <20 Escola Casas et al. (2015)
MWWTPAS + trickling filter (UKa) 14 Kasprzyk-Hordern et al. (2009)
MWWTP (+ industrial) AS (UKa) 72 Kasprzyk-Hordern et al. (2009)
HWWTP MBR (pilot scale) (CHb) <60 Kovalova et al. (2012)
MWWTPAS + UV (TWa) NR Lin et al. (2010)
MWWTPAS + chlorination (TWa) NR Lin et al. (2010)
MWWTPAS + chlorination (TWa) 77 Lin et al. (2010)
MWWTPAS + sand filter (TWa) NR Lin et al. (2010)
MWWTP trickling filter + chlorination (TWa) 56 Lin et al. (2010)
MWWTPAS + chlorination (TWa) NR Lin et al. (2010)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 37 Nielsen et al. (2013)
MWWTP MBR (hollow fiber membrane) (CANa) 12 Kim et al. (2014)
Cyclophosphamide HWWTP MBR (pilot scale) (CH) <20 Kovalova et al. (2012)
HWWTP MBR (pilot scale) (ceramic UF) (DK) 12 Nielsen et al. (2013)
Caffeine HWWTPAS + disinfection (GR) 75 Kosma et al. (2010)
MWWTPAS + sand filter (GR) 89 Kosma et al. (2010)
MWWTPAS + UV (TW) 99 Lin et al. (2010)
MWWTPAS + chlorination (TW) >99 Lin et al. (2010)
MWWTPAS + chlorination (TW) 97 Lin et al. (2010)
MWWTPAS + sand filter (TW) 99 Lin et al. (2010)
MWWTP trickling filter + chlorination (TW) 96 Lin et al. (2010)
MWWTPAS + chlorination (TW) >99 Lin et al. (2010)
MWWTP MBR (hollow fiber membrane) (CAN) 100 Kim et al. (2014)
AS activated sludge,MBR membrane bioreactor,MBBR moving bed biofilm reactor, UF ultrafiltration, NR no removal, CAN Canada, CH Switzerland,
DK Denmark, ES Spain, GR Greece, TW Taiwan, UK United Kingdom
a Erythromycin·H2O
b Erythromycin + Eryt·H2O (30–100 %)
c Flat sheet microfiltration
dHollow fiber UF
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process is the most common treatment process employed at
wastewater treatment plants; previous studies have indicated a
significant variation in the removal of pharmaceutical com-
pounds during treatment using the AS process, ranging from
complete removal (e.g., paracetamol and ibuprofen) to poor
removal (e.g., carbamazepine). Differences between removal
rates from various processes have also been studied. No sig-
nificant differences in the removal efficiency of certain com-
pounds (e.g., ibuprofen, triclosan, and caffeine) were found
between the MBR and conventional AS processes by
Oppenheimer et al. (2007). Pilot and laboratory-scale experi-
ments by Nielsen et al. (2013) found that removal of many
active pharmaceutical ingredients could be effectively
achieved using MBR plus ozone, ozone + hydrogen peroxide
or powdered activated carbon (PAC), with MBR + PAC being
the most efficient technology. MBBRs were found to be a
potentially promising solution for treatment of hospital
wastewater, with high elimination rates (>80 %) ob-
served for some compounds (ibuprofen, propranolol,
acetyl-sulfadiazine) in batch experiments, however, with low
elimination rates (<20 %) observed for others (sulfamethoxa-
zole, venlafaxine, iopromide, tramadol, and diatrizoic)
(Escola Casas et al. 2015).
Some studies have also investigated the biodegradation
efficiency of some pharmaceutical compounds under anaero-
bic processes (Carballa et al. 2007; Musson et al. 2010). The
reported biodegradation efficiency has varied from no elimi-
nation to high elimination. For example, Carballa et al. (2007)
observed significant elimination rates for some antibiotics
(sulfamethoxazole) and natural estrogens, while there was
no elimination of carbamazepine. Musson et al. (2010) inves-
tigated the fate of six pharmaceutical compounds (17α-
ethynylestradiol, acetaminophen, acetylsalicylic acid,
ibuprofen, metoprolol tartrate, and progesterone) during an-
aerobic digestion and only found a significant biodegradation
potential for acetylsalicylic acid.
The level of removal efficiency by biological treatments
depends on the physicochemical properties of the compounds,
the type of wastewater treatment technology, the hydraulic
retention time (HRT), the solids retention time (SRT), and
the climatic conditions (e.g., dilution, rainfall, temperature,
and level of sunlight) (Kasprzyk-Hordern et al. 2009;
McAdam et al. 2010; Sahar et al. 2011). The variation mainly
occurs because these parameters, and other physicochemical
properties of compounds, affect microbial activity and growth,
thereby resulting in a change in effluent quality (Pollice et al.
2002; Fernandez-Fontaina et al. 2012; Arévalo et al. 2014;
Chen et al. 2014).
Temperature conditions in biological wastewater treatment
processes can significantly affect microbial activity and
growth (LaPara et al. 2000; Vieno et al. 2005; Massmann
et al. 2006; Calderón et al. 2012). Previous studies in this field
have only investigated the removal efficiency of
pharmaceutical compounds in AS in response to seasonal var-
iations in temperature in Europe and North America (average
<20 °C). Relatively low removal efficiencies have been ob-
served, especially during the winter period (Heberer 2002;
Kolpin et al. 2002; Metcalfe et al. 2003; Miao et al. 2005).
However, temperature stability in the biological wastewater
treatment processes may be an important factor in
micropollutant removal, particularly in arid and semiarid
areas, where the average annual temperature is >25 °C. In arid
and semiarid areas, such as Saudi Arabia, the diurnal temper-
ature during summer can range between 30 and 55 °C, with an
annual average of above 30 °C (Aksakal and Rehman 1999;
Qadir et al. 2010; Almazroui et al. 2014). This will consequen-
tially result in higher temperatures in wastewaters compared to
both winter and summer conditions in temperate countries. In
addition to temperature, scarcity of available rainfall and in-
tense sunlight can affect removal efficiency (Hai et al. 2011).
This study aims to investigate the occurrence and fate of se-
lected pharmaceutical compounds at onsite hospital wastewa-
ter treatment plants (HWWTPs) in Riyadh (Saudi Arabia)
operating under high ambient temperature conditions.
Materials and methods
Treatment plant selection
Two HWWTPs were selected in central Saudi Arabia, both of
which were located in Riyadh. The choice of these locations
was based on the following factors: (i) the HWWTPs per-
formed onsite treatment; and (ii) the HWWTPs at both hospi-
tals employed AS processes. As far as was known, all other
HWWTPs in Riyadh (in fact, the entire country) employedAS
processes; therefore, the sites selected in this study should
generally be representative of HWWTPs in Saudi Arabia.
The known operational parameters at the two HWWTPs are
described in Table 2. For the purposes of this study, the sample
collection locations are referred to as sites HWWTP1 and
HWWTP2. Due to limited access to data, some infor-
mation on the operational processes at the HWWTPs
was not available (e.g., the HRT and SRT, among other
operational parameters that are commonly measured).
The wastewater at each hospital consists of a similar combi-
nation of units including outpatients, inpatients, medical units,
restaurants, and laundry, with the only difference being the
absence of a urology unit at HWWTP2.
Sampling
Figure 1 summarizes the treatment processes used at each
plant. Samples were collected from the influent (before the
secondary treatment) and effluent (after the tertiary treatment)
of each HWWTP. Sampling was carried out twice weekly for
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4 weeks in April 2014. One sample of influent and one sample
of effluent were collected on each sampling day. Samples
were collected in the middle of the day (between 11:00 and
14:00) when the air temperature was at its highest (30–35 °C).
The samples were collected by grab sampling in 1000-mL
sterile plastic bottles (Saudi Water, Saudi Arabia) and trans-
ferred to the laboratory in a cool box, and then frozen at
−20 °C. All the samples collected from each respective sam-
pling point (influent and effluent) (8× 1000 ml each) were
mixed together to provide a composite sample for the sam-
pling period. Three aliquots of 1000 mL of the mixed samples
for each site were then taken for analysis. This allowed an
assessment of the levels of pharmaceutical compounds present
in the influents and effluents of the HWWTPs in the middle of
the day, which likely represented the highest daily water tem-
peratures and the maximum loads received by the HWWTPs
(Ort et al. 2010).
Analysis of pharmaceutical compounds
The pharmaceutical compounds investigated in this study
were representative of the wide range of pharmaceutical com-
pounds commonly present in municipal wastewaters (Yu et al.
2006; Lin et al. 2010; Helwig et al. 2013). These compounds
included antibiotics, analgesics, β-blockers, anesthetics, anti-
convulsants, cytostatic antineoplastics, and lipid regulators.
Caffeine concentrations were also analyzed. Sample analysis
was carried out by an external laboratory (School of
Engineering and Built Environment, Glasgow Caledonian
University, United Kingdom).
Sample preparation
The pharmaceutical compounds were extracted using solid
phase extraction (SPE). The triplicate subsamples (1000 mL)
from each of the sampling points were filtered sequentially
through 100-, 1.6-, and 0.7-μm glass microfiber filters
(Whatman, UK), and then through a 0.45-μm cellulose nitrate
membrane sterile filter (Whatman, UK). Each filtered sample
was adjusted to pH 2.0 (±0.1) with the addition of 0.5 M
hydrochloric acid. Prior to extraction, the Strata-X (1-g/
20-mL, 33 μ polymeric reversed-phase) cartridges
(Phenomenex, UK) were preconditioned with 2 mL of meth-
anol and 2 mL of distilled water. Subsequently, the samples
were loaded at a flow rate of 10mL/min using an SPE vacuum
manifold with 12 accessories (Macherey-Nagel, Germany).
The cartridges were dried under a vacuum. After extraction,
the cartridges were washed with 3×2-mL water (18 MΩ cm)
and then eluted with 4 × 2-mL CH3CN/MeOH containing
0.1 % formic acid. The samples were then dried under nitro-
gen gas. The dried samples were reconstituted into CH3CN/
H2O (30/70). The samples were then diluted further (1:8) by
100-μL aliquot and adding 700 μL of CH3CN/H2O. The
dilution of samples helped to minimize matrix effects; how-
ever, this was not completely eliminated. Acetonitrile used
was Optima grade (Fisher). Deuterated internal standards
were added to afford a concentration of 5 μg/L prior to liquid
chromatography/tandem mass spectrometry (LC–MS/MS)
analysis. Deuterated internal standards used were atenolol
(d7), carbamazepine (d8), lidocaine (d10), paracetamol (d3),
and caffeine (d3), purchased from CDN isotopes.
Pharmaceutical standards used were Sigma-Aldrich HPLC
standard grade.
LC–MS/MS analysis
Each composite sample was analyzed in triplicate.
Chromatographic separation of the analytes was performed
using LC–MS/MS (Thermo Scientific Q Exactive
Quadrupole–Orbitrap Mass Spectrometer) equipped with a
column: Waters Xselect HSS T3. 2.1×150 mm (Water, UK).
The MS positive ion mode and experiment type are listed in
Table 3 along with linear range, retention times, and limits of
quantification (LOQs). The samples were bracketed by cali-
bration line and quality control standards (calibration line
criteria of ±20 % linear calibration with a weight of 1/x2).
Conditions included electrospray ionization, positive
ion mode, full scan range of 100–1000, mass resolution
of 17,500, targeted MS2 mass resolution of 17,500, spray
voltage of 3.5 kV, capillary temperature of 300 °C, and auxil-
iary gas heater of 300 °C. Some compounds were analyzed in
MS2, while those that fragmented less well were analyzed in
full scan mode.
Results and discussion
Occurrence of pharmaceutical compounds in hospital
wastewater
Out of the 12 compounds analyzed, 9 pharmaceutical com-
pounds were detected, including 3 antibiotic compounds (cip-
rofloxacin, clarithromycin, sulfamethoxazole) and the antibi-
otic metabolite, NACS, one analgesic (paracetamol), one
stimulant (caffeine), one β-blocker (atenolol), one anesthetic
(lidocaine), and one anticonvulsant (carbamazepine). The oth-
er compounds tested for, including bezafibrate, erythromycin,
and cyclophosphamide were not detected in either the influ-
ents or effluents of the HWWTPs. Mean concentrations are
presented in Table 4. Removal efficiencies were calculated as
difference between mean concentrations in influent and
effluent.
Caffeine and paracetamol were detected in all of the influ-
ent samples and were present at the highest concentrations of
all the compounds analyzed, up to 7479 and 12,390 ng/L,
respectively. Especially high concentrations of caffeine
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(>90 μg/L) were found at the HWWTP1 influent. Caffeine
has been detected in MWWTPs in China at concentrations at
3.4–6.6 μg/L (Sui et al. 2010), in Switzerland at 7–73 μg/L
(Buerge et al. 2003), and in Spain at concentrations up to
89 μg/L (Martín et al. 2012). Alidina et al. (2014) reported
high concentrations of caffeine (64–16,500 ng/L) in the efflu-
ent of six Saudi MWWTPs (but no data were available for
influent concentrations in their study). The high concentra-
tions of caffeine observed in this study may be related to its
administration in combination with other medication in order
to enhance the effects of certain analgesics in cough, cold, and
headache medicines (Lin et al. 2010; Weigel et al.
2002). It is also used as a cardiac, cerebral, and respi-
ratory stimulant and as a diuretic (Buerge et al. 2003). Both
caffeine and paracetamol were almost completely removed
during the treatment process in both of the HWWTPs.
Negligible concentrations of paracetamol were detected in
the both HWWTP effluents, while the removal efficiencies
for caffeine were near 100 %.
As expected, the hospital influents were found to contain
high levels of antibiotics and three of the antibiotic compounds
examined (ciprofloxacin, clarithromycin, sulfamethoxazole)
and the sulfamethoxazole metabolite, NACS, were detected
at concentrations ranging from 30 to 5611 ng/L in the influents
of the HWWTPs. The high concentrations of the antibiotics in
the raw hospital wastewater are likely to be present due to the
high levels of antibiotic consumption in hospitals (Kümmerer
2009). Ciprofloxacin was present in both influents at the
highest concentrations of the antibiotic compounds tested,
followed by NACS at concentrations up to 5611 and
1234 ng/L, respectively. Relatively low concentrations
(<160 ng/L) of sulfamethoxazole and clarithromycin were de-
tected in the raw hospital wastewater. Previous studies have
also found high concentrations of sulfamethoxazole (730 ng/L)
in Saudi effluents fromMWWTPs (Alidina et al. 2014). In this
study, the concentrations of all the antibiotics in the effluents of
the HWWTPs were found to be negligible and lower than their
respective predicted no effect concentrations (PNECs) reported
in the literature of 9.38×105 ng/L for ciprofloxacin, 70 ng/L
for clarithromycin, and 27 ng/L for sulfamethoxazole
(Verlicchi et al. 2012).
Carbamazepine, atenolol, and lidocaine were consistently
detected in the influent samples of the HWWTPs at relatively
low concentrations (<1 μg/L). Previously, atenolol was detect-
ed at low concentrations (1–4 ng/L) in the influent of a Saudi
MWWTP (Shraim et al. 2012). These drugs have been con-
sidered relatively recalcitrant to biological treatment and are
generally only partially removed in wastewater treatment sys-
tems (Zhang et al. 2008; Paxeus 2004; Rúa-Gómez and
Püttmann 2012). In this study, negligible concentrations of
these drugs were detected in the effluents of the HWWTPs.
These concentrations are lower than their respective PNECs of
1.38 × 104 ng/L for carbamazepine and 3.0 × 104 ng/L for
atenolol (Verlicchi et al. 2012) and the PNEC of
1.06 × 105 ng/L for lidocaine as reported by AstraZeneca
(2013). The concentrations of atenolol in effluent fall within
the lower range of concentrations previously report for efflu-
ents of various MWWTPs in Saudi Arabia (15–2550 ng/L);
however, carbamazepine in effluent was lower than levels
previously reported (57–1200 ng/L) (Alidina et al. 2014).
Table 2 Overview of the operational parameters at the two hospital
wastewater treatment plants studied
Parameters HWWTP1 HWWTP2
Number of beds 300 215
Annual wastewater volume (m3) 330,000 227,000
Process technology Aerobic Aerobic
Ambient (°C) 28± 7 28± 7
pH 7.0–7.5 6.8–7.5
Influent Effluent Influent Effluent
COD (mg/L) 376 64 336 27
NH4
+ (mg/L) 22.3 0.3 19.0 0
NO2
− (mg/L) 0.3 0.6 0.3 0.3
NO3
− (mg/L) 0.2 0.7 0.4 2.4
Fig. 1 Schematic of the
treatment processes employed in
the a hospital wastewater
treatment plant 1 and b hospital
wastewater treatment plant 2;
(X = sampling point)
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Potential influence of the operational parameters
on removal efficiencies
The removal efficiencies of pharmaceutical compounds from
the hospital wastewater samples show that, on average, the
highest decreases in effluent concentrations were observed
for ciprofloxacin, caffeine, sulfamethoxazole, paracetamol,
and NACS (> 95 %), followed by atenolol, carbamazepine,
and clarithromycin (>85 %). The average removal efficiency
of lidocaine was greater than 65 % at the two HWWTPs
(Fig. 2).
Paracetamol and caffeine
Caffeine and paracetamol were both almost completely re-
moved during treatment in each of the HWWTP. The average
removal efficiency of paracetamol was >98 %, while the caf-
feine was nearly completely (>99 %) removed by both
HWWTPs. Similar results were obtained for the removal of
paracetamol (up to 99 %) in AS processes by Kasprzyk-
Hordern et al. (2009) and Verlicchi et al. (2013), under tem-
perate climate conditions. Thus, paracetamol removal at
WWTPs seems possible using conventional ASP under wider
climate conditions (in both cold and warm weather). With
regard to the removal of caffeine, Lin et al. (2010) reported
similar caffeine removal efficiencies (99 %) in six Taiwanese
WWTPs. In contrast to these results, Buerge et al. (2003)
found that the removal efficiencies of caffeine varied (81–
99 %) at 13 Swiss MWWTPs. The authors indicated that the
MWWTPs that were less efficient at removing caffeine (81%)
employed lower adaptation times for the microorganisms in
the AS system (<5 days versus >5 days). Bacterial ad-
aptation in AS systems is enhanced through longer
SRTs and higher temperatures (Batt et al. 2006).
Therefore, in this study, the effective biodegradation of both
compounds may have resulted from the high ambient temper-
atures and/or the possibility that both plants may have been
operating with HRTs and SRTs that encouraged greater micro-
bial adaptation.
Antibiotics
The mean removal eff iciencies of ciprofloxacin,
clarithromycin, sulfamethoxazole, and NACS were >99, 86,
>98, and 97 %, respectively. The HWWTP2 achieved almost
complete removal of the antibiotics. Lin et al. (2009) previ-
ously studied sulfamethoxazole and clarithromycin and re-
ported that the removal efficiencies of six different Taiwan
WWTPs were greater than 50 and 20 %, respectively.
Carballa et al. (2004) also found a lower removal efficiency
(<60 %) of sulfamethoxazole in an AS plant located in tem-
perate climate conditions (Galicia, Spain). A seasonal varia-
tion in the removal of sulfamethoxazole was observed, with a
higher removal rate in summer (71 %) than in winter (17 %),
in Italy (Castiglioni et al. 2006). These results, and others
listed in Table 1, are all much lower than the results observed
in this study. Other studies observed the deconjugation of its
metabolite (NACS), and thus higher concentrations of sulfa-
methoxazole in the effluent compared to the influent (Ashton
et al. 2004; Göbel et al. 2007; Shelver et al. 2008). In this
study, the high removal efficiencies of both sulfamethoxazole
and NACS were observed under tropical climate conditions
and no concentrations of sulfamethoxazole were detected in
the effluent samples.
The other antibiotic (ciprofloxacin) was also completely
removed (>99 %) in both HWWTPs. Gao et al. (2012) report-
ed a lower removal efficiency (67%) in a Chinese AS process.
Ciprofloxacin is a fluoroquinolone and it is known that ad-
sorption to sludge is a major removal process. For example, a
significant amount of ciprofloxacin (up to 90%) was removed
Table 3 Mass spectrometry: positive ion mode, range, and limit of quantification (LOQ)
Analyte MS ion/transitiona Retention time (min) MS experiment Linear range (ng/ml) LOQ (ng/ml)
Atenolol 267.1703 6.38 Full scan 0.1–500 5
Bezafibrate 362.11–316.1089 19.63 Targeted MS2 0.1–500 0.1
Carbamazepine 237.10–194.0964 17.72 Targeted MS2 0.25–500 0.25
Caffeine 195.0877 7.20 Full scan 2.5–500 2.5
Ciprofloxacin 332.14–288.1505 7.43 Targeted MS2 0.25–500 2.5
Clarithromycin 748.48–158.1176 19.08 Targeted MS2 0.1–250 0.5
Cyclophosphamide 261.03–140.0029 10.68 Targeted MS2 0.5–500 1
Erythromycin 734.47–158.1176 14.99 Targeted MS2 0.5–500 0.5
Lidocaine 235.1805 7.88 Full scan 1–500 1
NACS 296.07–134.0602 10.69 Targeted MS2 2.5–500 5
Paracetamol 152.0706 6.80 Full scan 0.5–500 0.5
Sulfamethoxazole 254.06–108.0445 10.59 Targeted MS2 1–500 1
a The underlined m/z being used for quantification
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via adsorption when the pH was less than 5.5 in a laboratory
experiment (Githinji et al. 2011). However, adsorption has
been observed to decrease with increasing temperatures
(Seedher and Sidhu 2007) and an increase in pH (pH>6)
(Githinji et al. 2011). In this study, the removal efficiency of
ciprofloxacin occurred under a high ambient temperature
(>26 °C) and normal pH (7–8) conditions; this indicates that
its removal was probably more as a result of biodegradation
than adsorption.
Carbamazepine
The removal efficiency of carbamazepine by WWTPs has
previously been found to be poor, mostly below 10 %
(Zhang et al. 2008). Removal rates from literature suggest
consistently low removal rates across treatment types as
shown in Table 1. In fact, increases in carbamazepine concen-
trations after wastewater treatment have been reported (Joss
et al. 2005; Vieno et al. 2007). In the HWWTPs in Saudi
Arabia in this study, a high average removal efficiency of
carbamazepine (>86 %) was observed. The HWWTP2
achieved >99 % removal of the compound. In Portugal,
Dordio et al. (2010) reported similar removal efficiencies in
wastewater collected in summer conditions (97 % removal,
average temperature 26 °C), but lower levels in wastewater
collected in winter conditions (88 % removal, average tem-
perature 12 °C), indicating an effect of temperature on biodeg-
radation rates. In addition to temperature effects, solar degra-
dation could play a major role in the removal of carbamaze-
pine. Donner et al. (2013) found that after 120 min of UV
treatment, the concentrations of carbamazepine in solution
were decreased to approximately 1 % of the starting
concentration. High ambient temperatures and exposure to
sunlight in Saudi Arabia may also have played a role in the
high removal efficiencies observed for carbamazepine. These
findings were unexpected; they suggest that conventional
WWTPs could remove carbamazepine under certain condi-
tions and that tropical climate conditions are potentially more
favorable than temperate ones.
Atenolol
The average removal efficiency of atenolol by the HWWTPs
was 89 %. The removal efficiencies of this compound report-
ed in the literature vary drastically from study to study. For
example, in WWTPs located in temperate climates (in
Europe), Paxeus (2004) reported a removal efficiency of
<10%, while Vieno et al. (2005) reported a removal efficiency
of 61 %. Castiglioni et al. (2006) found that the removal effi-
ciency of atenolol was affected by temperature, where higher
removal efficiencies were achieved in summer (55 %) than in
winter (10 %). This indicates that the high removal efficien-
cies achieved by the HWWTPs in Saudi Arabia observed in
this study could be due to higher microbial activity in the
tropical climate.
Lidocaine
The average removal efficiency of lidocaine by the HWWTPs
was 64 %; however, the difference between removal at
HWWTP1 and HWWTP2 was large with 28 and >99 % re-
moval observed respectively. The removal efficiency of lido-
caine was assessed at various WWTPs in a temperate climate
(Hesse, Germany), where it was found to be significantly
Table 4 Concentrations of pharmaceutical compounds in hospital wastewater treatment plants in Saudi Arabia (ng/L)a
Class Compound LOQb HWWTP1 HWWTP1 HWWTP2 HWWTP2
Inf. Eff. Inf. Eff.
Analgesics Paracetamol 0.5 12400 ± 340 73 ± 11 12300 ± 180 157 ± 20
Antidepressants Carbamazepine 0.25 151 ± 13 41 ± 1 73 ± 14 n/d
β-blockers Atenolol 5.0 730 ± 82 46 ± 2 329 ± 28 55± 4
Lipid regulators Bezafibrate 0.1 n/d n/d n/d n/d
Anesthetics Lidocaine 1.0 158 ± 12 114± 4 129 ± 6 <LOQ
Antibiotics Ciprofloxacin 2.5 5600± 660 n/d 2180 ± 250 n/d
Clarithromycin 0.5 83± 72 22 ± 9 38 n/d
Sulfamethoxazole 1.0 30± 7 n/d 132 ± 5 n/d
Erythromycin 0.5 n/d n/d n/d n/d
Metabolite of sulfamethoxazole NACS 5.0 1200± 55 59 ± 14 506 ± 21 n/d
Cytostatic Cyclophosphamide 1.0 n/d n/d n/d n/d
Others Caffeine 2.5 74,800± 15,500,502 n/d 27,500± 2000 n/d
n/d not detected
a Each sample was analyzed in triplicate. Results are reported as mean ± standard deviation (n= 3)
b Limit of quantitation (substances detected but not quantifiable); n/d= not detected
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lower (10–50 %) (Rúa-Gómez and Püttmann 2012) than that
observed in this study. Kovalova et al. (2012) also found only
moderate removal of lidocaine in a pilot-scale MBR treating
hospital wastewater.
Discussion of the importance of key factors
on removal efficiency
The removal efficiencies of selected pharmaceutical
compounds measured in this study appeared to be much
improved in the hotter, tropical climate of Saudi Arabia.
Other studies have found that higher removal effi-
ciencies are observed during the summer in temperate
climates, by an average of 25 %, compared to winter
(Vieno et al. 2005). In another study, which examined
six large WWTPs in Italy, Castiglioni et al. (2006) also
found higher removal efficiencies in summer (18.6 °C)
than in winter (9.7 °C), except for the removal efficien-
cies of carbamazepine and ciprofloxacin, which were
similar across the two seasons. In this study, >99 %
removal efficiencies in relation to ciprofloxacin at both
HWWTP and carbamazepine at HWWTP2 were
achieved. In addition, very high removal efficiencies
regarding the antibiotics, atenolol, and lidocaine were
achieved; these compounds are normally found to be
persistent in conventional WWTPs in temperate climates
(Paxeus 2004; Rúa-Gómez and Püttmann 2012; Carballa
et al. 2004). Thus, the higher ambient temperatures
(>26 °C), which are present almost year-round in the
tropical Saudi Arabian climate, may have enhanced the
removal efficiencies of these compounds. This is because the
tropical conditions may have led to a high level of microbial
activity during the AS process, which may, in turn, have in-
creased the biodegradation kinetics. This theory is supported
by the knowledge that microorganisms living in reactors at
WWTPs usually reach their optimal activity rates at warm
temperatures, 25–35 °C (Cruikshank and Gilles 2007;
Kareem 2013).
Other factors, such as sunlight availability (which is impor-
tant for photodegradation), may also have influenced the re-
moval efficiency of the pharmaceutical compounds
(Kasprzyk-Hordern et al. 2009), particularly carbamazepine
(Donner et al. 2013). It should be noted, however, that remov-
al from effluent does not necessarily result in reduced toxicity.
In the experiments by Donner et al. (2013), UVexposure was
found to coincide with both a decrease in carbamazepine, but
also an initial increase in degradation products acridine and
acridone, which were shown to be significantly more toxic in
acute toxicity assays than carbamazepine. More comprehen-
sive studies are needed to investigate the multiple factors that
cause parent compound degradation, but potential formation
of recalcitrant degradation byproducts, and the relative
toxicity.
In addition, the HWWTPs assessed in this study applied
tertiary treatments, in the forms of sand filtration and disinfec-
tion. It is possible that sand filtration had an effect on the
removal efficiencies of the pharmaceutical compounds.
However, the removal of pharmaceutical compounds during
sand filtration has generally been reported to be inefficient
(Hollender et al. 2009; Nakada et al. 2007; Lin et al. 2010;
Kosma et al. 2010). Therefore, in this study, although the
samples were collected after the final treatment, in the inter-
pretation of the results, it has been assumed that sand filtration
played negligible roles in the fate of the target micropollutants
in the plants. However, the contribution of the tertiary






































































Fig. 2 Removal efficiencies of
pharmaceutical compounds at
HWWTP1 and HWWPT2 in
Saudi Arabia. Results shown are
mean removal (n = 3)
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treatments to the removal of the pharmaceutical compounds
requires investigation.
The role of chlorination may also be significant for some
compounds. Removal of antibiotics, including sulfamethoxa-
zole and ciprofloxacin (Li and Zhang 2012; Dodd et al. 2005),
endocrine disrupting compounds and anti-inflammatory drugs
(Noutsopoulos et al. 2015) have been shown to be af-
fected by chlorination, with pH influencing the level of
removal achieved. For acidic pharmaceuticals, some
compounds have been found to degrade significantly
due to chlorination (salicylic acid, naproxen, diclofenac,
indomethacin); however, chlorine does not seem to lead to
degradation of others (bezafibrate, ketoprofen, ibuprofen)
(Quintana et al. 2010).
Finally, only the liquid wastewater was tested in this study
and it is possible that the pollutants were adsorbed onto the
sludge. It is noted that some substances will be more prevalent
to sorption to sludges than others. Carbamazepine for example
displays extremely low sorption to sludges, and sulfamethoxa-
zole shows low sorption therefore removal by sorption to sludge
is unlikely to be a primary removal mechanism for these com-
pounds, whereas atenolol displays moderate sorption therefore
some removalmay be due to sorption (Horsing et al. 2011). This
is an area for further study and investigation in tropical climates.
Conclusions
The onsite HWWTPs in Saudi Arabia achieved high removal
efficiencies from wastewater of the pharmaceutical com-
pounds tested, including ciprofloxacin, clarithromycin,
sulfamethoxazole and NACS, paracetamol, caffeine,
atenolol, lidocaine, and carbamazepine, from the waste-
water. The high removal efficiencies of carbamazepine,
in particular, were unexpected due to the recalcitrant
nature of this compound. Temperature, and potentially
photodegradation, were identified to be factors that probably
led to the high removal efficiencies achieved. More work is
needed to confirm the role that these, and other potential fac-
tors, play.
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